Schedule I in the U.S.Serious cardiac riskNot FDA-approvedNo dosing or referrals

Claim extract · Listening Library

Mulligan: safety, ethics, and marketplace literacy

LAST REVIEWED 2026-09-22 · MEDIA CLAIM EXTRACT · HIGH-CONFIDENCE LL

High-confidence Listening Library safety-advocacy row (Modern Psychedelics Ep. 119, Juliana Mulligan). Lived-experience public education about cardiac risk and marketplace ethics — not clinical endpoints and not a how-to.

Listening Library source (outbound)

modern-psychedelics-119-mulligan-2025 — Apple Podcasts episode. Confidence: high. Primary URL verified HTTP 200 (2026-09-22 PT).

Testable claims (media → desk)

  1. Claim: Safety talk in podcasts replaces peer-reviewed cardiac literature.
    Desk: QTc / cardiac safety · Safety desk — advocacy media points to primaries; it is not the primary.
  2. Claim: Ethical marketplace language implies “natural” or plant-based sources are safe.
    Desk: Natural ≠ safe — source ethics ≠ cardiac risk elimination.
  3. Claim: Clinic ethics discussion equals evidence of efficacy or referral guidance.
    Desk: Clinic success-rate claim check · IbogaBase does not refer clinics.
  4. Boundary: No dosing, no DIY instructions, no provider referrals — pair DIY / self-treatment limits.

Verdict

Strong safety/ethics media extract; does not authorize treatment, dosing, or clinic choice, and does not replace peer-reviewed cardiac sources.

Continue reading

Safety · QTc · Natural ≠ safe · Listening Library